Martin Aringer Selected Research

Hyperuricemia

8/2009	Gout--current diagnosis and treatment.
4/2008	SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Aringer Research Topics

Disease

24	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2003
14	Lupus Nephritis 01/2022 - 10/2004
10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2003
9	Rheumatoid Arthritis 09/2022 - 05/2005
8	Systemic Scleroderma (Systemic Sclerosis) 03/2022 - 08/2005
8	Arthritis (Polyarthritis) 01/2019 - 10/2004
7	Giant Cell Arteritis (Horton Disease) 05/2022 - 01/2017
7	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022 - 11/2009
7	Rheumatic Diseases (Rheumatism) 01/2022 - 05/2008
6	Infections 11/2021 - 11/2004
5	Connective Tissue Diseases (Connective Tissue Disease) 03/2022 - 12/2007
4	Fatigue 09/2022 - 07/2012
4	Inflammation (Inflammations) 01/2022 - 11/2009
4	Proteinuria 01/2020 - 10/2004
4	Necrosis 01/2020 - 11/2011
3	Pain (Aches) 09/2022 - 01/2003
3	Virus Diseases (Viral Diseases) 01/2022 - 11/2004
3	Mixed Connective Tissue Disease (MCTD) 02/2012 - 08/2005
3	Gout 01/2011 - 04/2008
2	Renal Insufficiency (Renal Failure) 09/2022 - 01/2011
2	Dermatomyositis (Dermatopolymyositis) 01/2022 - 09/2014
2	Delirium 01/2021 - 12/2019
2	Alopecia (Baldness) 12/2020 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2020 - 03/2012
2	Fever (Fevers) 12/2019 - 01/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2019 - 11/2016
2	Vasculitis (Vasculitides) 11/2012 - 05/2011
2	Pneumonia (Pneumonitis) 03/2012 - 11/2009
2	Hyperuricemia 08/2009 - 04/2008
2	Nephritis 07/2008 - 10/2004
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2022
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Disease Progression 02/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Panniculitis 01/2022
1	Diarrhea 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	COVID-19 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	malar rash 12/2020
1	Oral Ulcer (Mouth Ulcer) 12/2020

Drug/Important Bio-Agent (IBA)

13	AutoantibodiesIBA 01/2020 - 01/2003
12	GlucocorticoidsIBA 09/2022 - 11/2012
9	tocilizumab (atlizumab)FDA Link 09/2022 - 11/2011
9	AntibodiesIBA 01/2021 - 08/2005
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 01/2003
8	Infliximab (Remicade)FDA Link 01/2020 - 10/2004
7	Rituximab (Mabthera)FDA Link 03/2022 - 05/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
6	Antirheumatic Agents (DMARD)IBA 01/2020 - 11/2011
5	nintedanibIBA 03/2022 - 01/2021
5	Antinuclear AntibodiesIBA 01/2022 - 02/2012
5	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2004
5	Tumor Necrosis Factor InhibitorsIBA 06/2017 - 01/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2022 - 06/2013
4	Edetic Acid (EDTA)FDA Link 04/2021 - 11/2012
4	Biological ProductsIBA 01/2020 - 02/2015
4	CytokinesIBA 07/2012 - 01/2003
3	Janus Kinase InhibitorsIBA 01/2022 - 06/2017
3	baricitinibIBA 01/2022 - 06/2017
3	Leflunomide (Arava)FDA LinkGeneric 11/2021 - 06/2017
3	Etanercept (Enbrel)FDA Link 01/2020 - 05/2005
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2019 - 03/2012
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2019 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2022 - 11/2004
2	Calcineurin InhibitorsIBA 01/2022 - 01/2020
2	Antimalarials (Antimalarial Agents)IBA 11/2021 - 03/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	Antiphospholipid AntibodiesIBA 12/2020 - 01/2019
2	Abatacept (Orencia)FDA Link 01/2020 - 06/2017
2	sarilumabIBA 01/2020 - 06/2017
2	Adalimumab (Humira)FDA Link 01/2020 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2002
2	Certolizumab Pegol FDA Link 01/2020 - 06/2017
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2017
2	Janus KinasesIBA 01/2020 - 06/2017
2	tofacitinibIBA 01/2020 - 06/2017
2	Biosimilar PharmaceuticalsIBA 01/2020 - 06/2017
2	C-Reactive ProteinIBA 01/2020 - 07/2002
2	golimumab FDA Link 01/2020 - 06/2017
2	AntigensIBA 09/2019 - 05/2008
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2016 - 06/2013
2	belimumabIBA 02/2015 - 01/2015
2	EnzymesIBA 01/2015 - 06/2013
2	Azathioprine (Imuran)FDA LinkGeneric 06/2013 - 10/2004
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	Uric Acid (Urate)IBA 08/2009 - 04/2008
2	CollagenIBA 08/2005 - 07/2002
1	ametantrone (HAQ)IBA 09/2022
1	Ligases (Synthetase)IBA 03/2022
1	voclosporinIBA 01/2022
1	anifrolumabIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2021

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2003
3	Immunomodulation 03/2022 - 01/2021
2	Plasma Exchange 01/2017 - 11/2004
1	Drug Therapy (Chemotherapy) 02/2022
1	Pain Management 10/2021
1	Stem Cell Transplantation 01/2021